Trials / Recruiting
RecruitingNCT06862089
A Prospective Study Evaluating the Impact of Conservative Management on Retained Products of Conception and EMV
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 120 (estimated)
- Sponsor
- Fu Xing Hospital, Capital Medical University · Academic / Other
- Sex
- Female
- Age
- —
- Healthy volunteers
- Not accepted
Summary
The goal of this observational study is to learn about the therapeutic effects of the conservative treatment approach on pepole with retained products of conception (RPOC) and Enhanced myometrial vascularity (EMV). The main question it aims to answer is: Is it possible to achieve the natural resolution of RPOC by combining it with EMV through conservative treatment? Participants will receive conservative treatment (such as mifepristone, GnRH-a, or expectant management) following the initial diagnosis of RPOC and EMV, and the therapeutic efficacy of the conservative approach will be assessed after the completion of two menstrual cycles.
Conditions
Timeline
- Start date
- 2024-10-23
- Primary completion
- 2026-10-31
- Completion
- 2026-12-30
- First posted
- 2025-03-06
- Last updated
- 2025-06-15
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06862089. Inclusion in this directory is not an endorsement.